feed,title,long_url,short_url
MarketWatch,Sarepta's stock is up 11% on positive data from clinical trial for Duchenne treatment,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/wmimrpM6T4A/story.aspx,https://on.mktw.net/3fqTwai
